Assets

Blog Post Filter

The hormone fibroblast growth factor 21 (FGF21) holds considerable promise as a therapeutic mechanism and understanding the physiology and the pharmacology of FGF21 is key to all drug development projects related to this field. In this performance data file, we present data for the FGF21 cell line ... Read more
Immunogenic responses, where antibodies are produced by the immune system as a protective response, can adversely affect the pharmacokinetics, bioavailability, and efficacy of biopharmaceuticals, and may even neutralize the activity of the drug. Many different factors influence the immunogenicity ... Read more
Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Non-canonical Functions of C1s Join us in this presentation to learn about the role of the complement system in renal cancer. Duration: ~17 minutes  Speaker: M. Revel, M. A. Dragon-Durey and L.T. Roumenina from Cordeliers ... Read more
How can IBD patients benefit from regular monitoring? Join us in a webinar and learn about how monitoring can help IBD patients today and in the future. Duration: ~60 minutes incl. Q&A Speaker: Mr. Charlie Lees, Professor of Gastroenterology, Western General Hospital, Edinburgh and Senior ... Read more